Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
4.090
+2.110 (106.57%)
At close: Jun 27, 2025, 4:00 PM
2.820
-1.270 (-31.05%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $154.08 million as of June 27, 2025. Its market cap has decreased by -41.60% in one year.
Market Cap
154.08M
Enterprise Value
40.45M
1-Year Change
-41.60%
Ranking
Category
Stock Price
$4.09
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $154.08M, a decrease of -68.44%. That is a compound annual growth rate of -25.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 74.59M | -72.87% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.07B |
| Johnson & Johnson | 367.86B |
| AbbVie | 329.17B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.62B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.38B |
| AstraZeneca | 215.99B |